Advent International (Advent), a global private equity investors, has entered into a definitive agreement to acquire significant stake in Suven Pharmaceuticals(Suven Pharma or Suven) from the Jasti family, subject to regulatory approvals and conditions. Post the completion of this landmark acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences (Cohance) with…
